India, Aug. 1 -- Scale, efficiency, and cost optimisation were the deciding factors for competitiveness in the global life sciences industry for decades. However, in an era shaped by geopolitical tensions, trade disruptions, inflationary pressures, regulatory shifts, and hindrances to global logistics, competitiveness is increasingly determined by resilience, adaptability, and supply chain intelligence.

Recently, it has been evident that the global production network is vulnerable. From shipping bottlenecks and rising freight costs to shortages of critical raw materials, active pharmaceutical ingredients (APIs) and specialised components, the life sciences sector has had to navigate persistent uncertainty. Export controls, regional confl...